Delivery as the rate-limiting step for cancer vaccines
…delivery strategies aimed at the immune system or the tumour and discuss trade-offs between platforms. The programme considers how manufacturing limits and combination regimens constrain feasible approaches, and how delivery decisions influence immune activation, clinical translation and production at scale.
Thu, Oct 22, 2026 · 15:00 UTC